Geode Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.42M | Buy |
523,831
+48,619
| +10% | +$975K | ﹤0.01% | 2415 |
|
|
2025
Q4 | $11.1M | Buy |
475,212
+3,983
| +0.8% | +$86.4K | ﹤0.01% | 2364 |
|
|
2025
Q3 | $9.4M | Buy |
471,229
+503
| +0.1% | +$9.03K | ﹤0.01% | 2442 |
|
|
2025
Q2 | $6.45M | Sell |
470,726
-2,604
| -0.6% | -$25K | ﹤0.01% | 2598 |
|
|
2025
Q1 | $5.24M | Buy |
473,330
+11,428
| +2% | +$122K | ﹤0.01% | 2628 |
|
|
2024
Q4 | $4.92M | Buy |
461,902
+6,265
| +1% | +$75K | ﹤0.01% | 2759 |
|
|
2024
Q3 | $5.79M | Buy |
455,637
+34,248
| +8% | +$508K | ﹤0.01% | 2685 |
|
|
2024
Q2 | $7.07M | Buy |
421,389
+97,437
| +30% | +$1.39M | ﹤0.01% | 2536 |
|
|
2024
Q1 | $4.86M | Buy |
323,952
+11,436
| +4% | +$187K | ﹤0.01% | 2722 |
|
|
2023
Q4 | $4.69M | Buy |
312,516
+93,389
| +43% | +$1.21M | ﹤0.01% | 2734 |
|
|
2023
Q3 | $3.07M | Buy |
219,127
+17,406
| +9% | +$279K | ﹤0.01% | 2890 |
|
|
2023
Q2 | $2.09M | Buy |
201,721
+187,345
| +1,303% | +$2.07M | ﹤0.01% | 3101 |
|
|
2023
Q1 | $133K | Hold |
14,376
| – | – | ﹤0.01% | 4234 |
|
|
2022
Q4 | $127K | Hold |
14,376
| – | – | ﹤0.01% | 4301 |
|
|
2022
Q3 | $119K | Hold |
14,376
| – | – | ﹤0.01% | 4493 |
|
|
2022
Q2 | $117K | Sell |
14,376
-161,837
| -92% | -$1.11M | ﹤0.01% | 4525 |
|
|
2022
Q1 | $1.53M | Buy |
176,213
+8,456
| +5% | +$65.9K | ﹤0.01% | 3395 |
|
|
2021
Q4 | $1.59M | Buy |
167,757
+13,572
| +9% | +$191K | ﹤0.01% | 3482 |
|
|
2021
Q3 | $2.59M | Sell |
154,185
-11,410
| -7% | -$181K | ﹤0.01% | 3241 |
|
|
2021
Q2 | $2.53M | Buy |
165,595
+430
| +0.3% | +$7.78K | ﹤0.01% | 3191 |
|
|
2021
Q1 | $3.22M | Buy |
165,165
+18,523
| +13% | +$393K | ﹤0.01% | 3005 |
|
|
2020
Q4 | $2.64M | Sell |
146,642
-1,963
| -1% | -$41.1K | ﹤0.01% | 2925 |
|
|
2020
Q3 | $2.87M | Sell |
148,605
-312
| -0.2% | -$7.07K | ﹤0.01% | 2689 |
|
|
2020
Q2 | $3.89M | Buy |
148,917
+11,332
| +8% | +$277K | ﹤0.01% | 2482 |
|
|
2020
Q1 | $2.45M | Buy |
137,585
+15,041
| +12% | +$406K | ﹤0.01% | 2567 |
|
|
2019
Q4 | $4.09M | Buy |
122,544
+12,780
| +12% | +$349K | ﹤0.01% | 2581 |
|
|
2019
Q3 | $2.62M | Buy |
109,764
+5,714
| +5% | +$187K | ﹤0.01% | 2779 |
|
|
2019
Q2 | $3.74M | Buy |
104,050
+88,475
| +568% | +$3.26M | ﹤0.01% | 2580 |
|
|
2019
Q1 | $575K | Buy |
15,575
+7,450
| +92% | +$312K | ﹤0.01% | 3383 |
|
|
2018
Q4 | $349K | Hold |
8,125
| – | – | ﹤0.01% | 3491 |
|
|
2018
Q3 | $383K | Buy |
8,125
+980
| +14% | +$45.5K | ﹤0.01% | 3556 |
|
|
2018
Q2 | $355K | Hold |
7,145
| – | – | ﹤0.01% | 3541 |
|
|
2018
Q1 | $355K | Hold |
7,145
| – | – | ﹤0.01% | 3516 |
|
|
2017
Q4 | $265K | Hold |
7,145
| – | – | ﹤0.01% | 3583 |
|
|
2017
Q3 | $225K | Buy |
+7,145
| New | +$158K | ﹤0.01% | 3633 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
